Biotechnology - Game-changing point-of-care assay could revolutionize Mpox detection worldwide
Can't see this email? View it online
   
  Biotechnology  
  The latest Biotechnology news from AZoNetwork  
 

Elevate Your Processes: Mass Spectrometry for FermentationElevate Your Processes: Mass Spectrometry for Fermentation

Discover the power of real-time fermentation process tracking with the latest application note.

Thermo Scientific™ Prima Process Mass Spectrometer offers fast, non-invasive analysis of respiratory gases, providing crucial insights into culture physiology, growth kinetics, and substrate consumption. With cutting-edge technology and 21 CFR Part 11 compliant software, it's time to elevate your processes.

Download now to learn more and optimize your fermentation!

Get Your Free App Note
 
   Game-changing point-of-care assay could revolutionize Mpox detection worldwideGame-changing point-of-care assay could revolutionize Mpox detection worldwide
 
Researchers from Australia developed a point-of-care assay for the rapid detection of mpox virus (MPXV) in clinical samples based on isothermal amplification along with clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein (Cas) technology.
 
   Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journalStudy evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal
 
Tiziana Life Sciences Ltd. today announced acceptance of a publication that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD).
 
 University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study
 
University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical studyIn 2021, the University of Birmingham and Acticor Biotech signed a partnership agreement to evaluate glenzocimab efficacy in myocardial infarction in a new clinical trial called LIBERATE.
 
 
 African BioGenome Project Bridges the Gap in Biodiversity Genomics and Bioinformatics
 
African BioGenome Project Bridges the Gap in Biodiversity Genomics and BioinformaticsSince its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.
 
 
 Research provides key insights into the molecular underpinnings of acute liver injury
 
Research provides key insights into the molecular underpinnings of acute liver injuryA team of researchers from Chonnam National University and the Korea Research Institute of Bioscience and Biotechnology unveiled important insights into liver injury and its underlying molecular mechanisms.
 
 
 Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug
 
Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drugClinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by US biopharmaceutical company Nuvectis Pharma, Inc.